copy of dr. borghaei on the current landscape of immunotherapy in nsclc
Published 6 years ago • 35 plays • Length 0:18Download video MP4
Download video MP3
Similar videos
-
2:03
dr. borghaei on the current landscape of immunotherapy in nsclc
-
0:24
copy of dr. borghaei on molecular profiling in lung cancer
-
1:11
dr. borghaei on immunotherapy versus chemotherapy and immunotherapy in nsclc
-
1:37
dr. borghaei on anticipated trials evaluating immunotherapy in nsclc
-
1:33
dr. borghaei on the fda approval of nivolumab in small cell lung cancer
-
1:54
the evolving landscape of immunotherapy in nsclc
-
9:17
the emerging landscape of immunotherapy in nsclc
-
1:29
dr. borghaei on the clinical utility of pd-l1 in advanced nsclc
-
1:36
dr. borghaei on the search for biomarkers in lung cancer
-
2:02
dr. borghaei on emerging biomarkers in nsclc
-
2:05
dr. borghaei on the management of immune-related side effects in lung cancer
-
1:41
dr. borghaei on reporting immunotherapy-related aes in lung cancer
-
1:02
dr. borghaei on immune-related adverse events in lung cancer
-
2:33
immunotherapy for lung cancer: current landscape and challenges
-
1:47
dr. langer on the current state of immunotherapy in advanced nsclc
-
0:31
copy of dr. brahmer on the role of immunotherapy in metastatic nsclc
-
1:36
dr. rudin on expansion of immunotherapy in lung cancer
-
2:08
dr. borghaei on second-line therapy in sclc
-
1:25
dr. brahmer on chemoimmunotherapy in patients with nsclc